New drugs in the treatment of B-lymphoproliferative disorders - highlights from ICML congress in Lugano, June 2013

Abstract

Traditional haematology congress discussing problems of lymfoprolilefative disordes held in Lugano, June 2013. Many new drugs in the field of lymphoma patients care have been discussed.

Three of them are discussed in this article – ibrutinib, idelalisib and ABT-199.

Keywords

• lymphoma
• CLL
• ibrutinib
• ABT-199